|
|
Life Science
|
|
Devices, Diagnostics, & Distribution
|
|
New medical technologies and breakthroughs have led to the use of gene-based diagnostics in the detection of diseases. These new diagnostics, driven by genomics and imaging technologies, are leading to a new area of interest, Theranostics. These new tools and therapies will have an impact on the evolving demographics.
Devices that utilize biotechnology are having an impact on the use of more traditional cardiology procedures. New interventional technologies and procedures in particular in the areas of minimally invasive surgery may reduce the use of some traditional techniques. The convergence of medical devices and pharmaceuticals will challenge traditional protocols and create new marketing opportunities along with challenging operations and regulatory issues. New product developments and/or acquisition will speed the development and implementation of these new technologies.
Practice Leaders:
John Baker - Boston
Supriya Dikshit - Mumbai
Sue Rossiter - St. Albans
John Spencer - San Francisco
Consultants:
Paul Bulteel - London
Clare Cizek - Minneapolis
Diane Coletti - Boston
Eric Dieny - Shanghai
Caroline Edwards - Hong Kong**
Boyd Falconer - Ann Arbor
Jeffrey Golove - New York
Rives Hewitt - Toronto
Sussannah Kelly - Toronto
Donald Kilinski - New York
Bertrand Kimper - New York
Victor Kleinman - Palm Beach
Kelvin Ling - Hong Kong**
Linda Madrid - Washington, DC
James Martin - Washington, DC
Tara McKernan - Stamford
Mike Nagata - Tokyo
Yen Pin Ng - Singapore
Bonnie Sharps - Philadelphia
Johannes Suciu - Frankfurt
Naomi Tachibana - Tokyo
Phoebe Wan - Hong Kong**
Jeffrey Webb - St. Albans
Jan Westerink - Amsterdam**
Lance Winn - Austin
Shawn Woessner - Minneapolis
|
|